Abstract
INTRODUCTION AND AIMS: The 3rd generation PTH assays detect the only total bioactive 1-84 fragment. Since standardization is still lacking, each new PTH assay requires to establish reference values and to assess the impact in the medical care of the mineral and bone disorders in CKD5 patients.